Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
NCT00007007 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59
Last updated 2020-10-22
Summary
RATIONALE: Assessment of patients undergoing radiation therapy may help to determine the effects of the treatment and may help improve cancer treatment.
PURPOSE: This clinical trial is studying the memory skills in patients receiving radiation therapy for brain metastases.
Conditions
- Cognitive/Functional Effects
- Metastatic Cancer
- Radiation Toxicity
Interventions
- PROCEDURE
-
management of therapy complications
- PROCEDURE
-
quality-of-life assessment
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Radiation Therapy Oncology Group
lead NETWORK
Principal Investigators
-
William F. Regine, MD · Lucille P. Markey Cancer Center at University of Kentucky
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 0 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-11-30
- Primary Completion
- 2004-12-31
- Completion
- 2004-12-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
NCT02360215 ·Status: COMPLETED ·Phase: PHASE3
-
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
NCT03184038 ·Status: RECRUITING ·Phase: NA
-
Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases
NCT00003324 ·Status: COMPLETED ·Phase: NA
-
The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC
NCT04193007 ·Status: UNKNOWN ·Phase: PHASE2
-
Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial
NCT06974370 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Impact of Neurocognitive Function in Patients With Multiple Brain Metastases Receiving Whole Brain Radiation Therapy
NCT03626818 ·Status: UNKNOWN
-
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
NCT00030628 ·Status: COMPLETED ·Phase: PHASE3
-
Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors
NCT00389584 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor
NCT00107367 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases
NCT06857006 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant vs. Intraoperative vs. Adjuvant Resection Cavity Radiotherapy of Brain Metastases
NCT05871307 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
NCT01891318 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
NCT07248228 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
NCT04804644 ·Status: RECRUITING ·Phase: PHASE3
-
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
NCT00003308 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases
NCT01890278 ·Status: UNKNOWN ·Phase: NA
-
Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
NCT00983359 ·Status: COMPLETED ·Phase: NA
-
Focal Intraoperative Radiotherapy of Brain Metastases
NCT03789149 ·Status: TERMINATED ·Phase: PHASE2
-
Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases
NCT01592968 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
NCT00031967 ·Status: COMPLETED ·Phase: PHASE2
-
Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
NCT03750227 ·Status: RECRUITING ·Phase: PHASE3
-
Pre-operative Stereotactic Radiosurgery Followed by Resection for Patients With Brain Metastases
NCT03398694 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases
NCT01644591 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Stereotactic Radiosurgery in Treating Patients With Brain Metastases
NCT00811655 ·Status: TERMINATED ·Phase: PHASE2
-
Radiation Therapy Following Surgery to Remove Brain Metastases
NCT00003320 ·Status: COMPLETED ·Phase: NA